S. Stark

The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia

W. Hoy, A. Mallett, V. Lee, 2020, BMC Nephrology.

The use of botulinum toxin type‐B in the treatment of patients who have become unresponsive to botulinum toxin type‐A – initial experiences

M. Barnes, D. Best, M. Barnes, 2005, European journal of neurology.

The prevalence of Fabry disease in a statewide chronic kidney disease cohort – Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study

W. Hoy, A. Mallett, V. Lee, 2022, BMC Nephrology.

Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool.

J. Fletcher, J. Szer, S. Stark, 2015, Clinica chimica acta; international journal of clinical chemistry.

Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study

J. Goldblatt, A. Mallett, Mark Thomas, 2020, Orphanet Journal of Rare Diseases.

Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples.

M. Gelb, F. Tureček, C. Auray-Blais, 2016, Clinical chemistry.

Efficacy and safety of two different antifungal pastes in infants with diaper dermatitis: a randomized, controlled study

S. Stark, PH Hoeger, G. Jost, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.